As of 9:50am ET
| +0.0006 / +0.15%|
The 2 analysts offering 12-month price forecasts for Opexa Therapeutics Inc have a median target of 5.00, with a high estimate of 6.00 and a low estimate of 4.00. The median estimate represents a +1,182.05% increase from the last price of 0.39.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.